IXO-702

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIXO-702

Drug Alias NameLTB4 inhibitor (IXO Therapeutics)IXO-702

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionLipocalins modulatorsLeukotriene B4 receptor antagonists

TargetsLeukotriene B4 receptorLipocalins

Therapy Area/IndicationsImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsImmune System Diseases

ATC CodeN/A